{"id":5387,"date":"2023-10-05T18:00:16","date_gmt":"2023-10-05T16:00:16","guid":{"rendered":"https:\/\/amoeba-nature.com\/?p=5387"},"modified":"2023-10-05T18:10:59","modified_gmt":"2023-10-05T16:10:59","slug":"amoeba-first-half-year-reporting","status":"publish","type":"post","link":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/","title":{"rendered":"Amo\u00e9ba: first half-year reporting\u00a0"},"content":{"rendered":"<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<h2 class=\"wp-block-heading\"><strong>Amo\u00e9ba: a first half-year mainly marked by the development of the biocontrol plant project&nbsp;<\/strong><\/h2>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Chassieu (France), October 5, 2023 \u2013 18:00 CET &#8211; AMO\u00c9BA (FR0011051598 &#8211; ALMIB), <\/strong>which is producing a biological biocide capable of eliminating the bacterial risk in water and a biocontrol product for plant protection, still in a development phase, is today reporting its earnings for the first half of 2023, ended June 30, 2023, as approved by the Board of Directors on October 5, 2023.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>At the end of 2022, Amoeba obtained approval of its active substance for biocidal use in closed cooling systems and for biocontrol use in the United States.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>As requested by the Company, the Statutory Auditors carried out a limited review of the consolidated half-year accounts at June 30, 2023 and did not identify any material misstatements that would call into question the compliance of these accounts.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The half-year report is currently being issued and will be published on the Company\u2019s website (www.amoeba-nature.com) over the coming days.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>&nbsp;<strong>Results that reflect the start of the industrial project and a significant reduction in the debt charges&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n\n<figure class=\"wp-block-image size-full is-resized\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/Capture-decran-2023-10-05-a-17.53.35.png\" alt=\"\" class=\"wp-image-5382\" style=\"width:840px;height:316px\" width=\"840\" height=\"316\" srcset=\"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/Capture-decran-2023-10-05-a-17.53.35.png 946w, https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/Capture-decran-2023-10-05-a-17.53.35-300x113.png 300w, https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/Capture-decran-2023-10-05-a-17.53.35-768x289.png 768w, https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/Capture-decran-2023-10-05-a-17.53.35-400x151.png 400w\" sizes=\"auto, (max-width: 840px) 100vw, 840px\" \/><\/figure>\n\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Operating income <\/strong>came to \u2013\u20ac3,882K at June 30, 2023, compared with \u2013\u20ac2,860K for the first half of 2022. No significant depreciation was recorded during the periods presented.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The Company did not generate any <strong>revenues <\/strong>during the first half of 2023.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The <strong>industrial deployment costs <\/strong>are \u20ac443K higher than the previous year, with this increase linked mainly to the transfer of consumable purchases and energy costs from the R&amp;D department to the industrial deployment department.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li><strong>Research and development <\/strong>costs net of grants represent \u20ac1,224K, compared with \u20ac1,306K for the first half of 2022.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li><strong>Sales and marketing <\/strong>costs are up 18% from the previous year (\u20ac227K at June 30, 2023, versus \u20ac192K at June 30, 2022).&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li><strong>Administrative costs and overheads <\/strong>increased by \u20ac755k compared with the previous year. This difference is mainly due to fees to secure financing and staff costs.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The <strong>financial result <\/strong>is no longer impacted by bank loans, which have all been repaid.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Half-year <strong>net income <\/strong>came to \u2013\u20ac4,002K, compared with \u2013\u20ac4,726K for the first half of 2022.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company\u2019s <strong>cash <\/strong>position at June 30, 2023 was \u20ac3,136K, compared with \u20ac5,528K at December 31, 2022.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The reduction in the cash position reflects:&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>cash flow from operating activities for \u2013\u20ac2,221K;&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>cash flow from investing activities for -\u20ac1,101K;&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>cash flow from financing activities for +\u20ac927K.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>At June 30, 2023, the Company\u2019s shareholders\u2019 equity represented \u20ac6.7m, compared with \u20ac8.2m at December 31, 2022.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company\u2019s financial debt totaled \u20ac667K, comprising liabilities relating to lease obligations (\u20ac667K), as the bonds convertible into shares with an incentive program (OCAPI) had all been converted.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>First half of the year marked primarily by the continued development of the biocontrol application and the new financing obtained&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>During the first half of 2023, Amo\u00e9ba focused on the following main areas:&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Industrial development:&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>On February 16, 2023, the Company announced that it had submitted the building permit application for its dedicated new production site for biocontrol applications, which will be located in Cavaillon in France\u2019s Vaucluse region.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>In line with the project\u2019s schedule, the building permit application, setting out robust commitments to respect biodiversity and employees, was approved on June 12, 2023, following a three-month review. With this project, Amo\u00e9ba aims to develop a dedicated industrial site of over 3,000 sq.m for the bio-production of its biocontrol agent. This major project is part of the industrialization plan launched by Amo\u00e9ba in preparation for the commercialization of its plant protection products expected for early 2025.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Continuing to develop the biocontrol application:&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ol class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Collaboration with Nissan Chemical Corporation&nbsp;<\/li>\n<\/div><\/div><\/div><\/ol>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>On March 31, 2023, Amo\u00e9ba announced that, under a material transfer agreement, Nissan Chemical Corporation has launched a study to assess the performance of a mixture combining one of its products with an experimental biocontrol product from Amo\u00e9ba.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ol class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Creation of the AXPERA brand&nbsp;<\/li>\n<\/div><\/div><\/div><\/ol>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>As part of its pre-commercialization plan, Amo\u00e9ba has developed an international brand for its biocontrol solution, reflecting the values of innovation, performance, responsibility and renewal. On June 5, 2023, it announced that the brand name for its biocontrol solutions would be AXPERA, with its release planned for early 2025.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Field tests continuing to make progress The objectives of the tests are primarily to:&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Assess AXPERA\u2019s efficacy and selectivity in the field on new targets (e.g. Arboriculture, Aromatic and ornamental plants, Strawberry, Garlic)&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Confirm AXPERA\u2019s efficacy and selectivity on mildew and Uncinula necator or powdery mildew affecting grapes.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Position the product within leading local agricultural programs in Europe.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Assess AXPERA\u2019s efficacy and selectivity with field tests for Soybean Rust in Brazil and Black Sigatoka affecting Bananas.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Consolidate our efficacy data to further strengthen the applications for approval of the formulated product.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Since 2019 and at the date of the half-year report, the Company has carried out 620 tests, including 200 partner tests. It will continue with its tests in 2023.&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Financing&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The Company announced the cancellation of the eighth optional tranche of 80 convertible bonds and the signing of a support contract with Redbridge Debt and Treasury Advisory, which aims to support the Company with adapting its financial strategy to its new industrial transformation challenges.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Alongside this, Amo\u00e9ba signed a new \u20ac9 million simple bond financing agreement with Nice &amp; Green (see press release from February 15, 2023) with a view to launching its industrial project immediately.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Amo\u00e9ba also obtained \u20ac5.9m of funding from BPI France under the France 2030 program following its application for the \u201c<em>Agrifood Capacity and Resilience<\/em>\u201d call for projects. BPI France announced \u20ac5,917,676 of support based on a \u20ac3,550,606 grant and a \u20ac2,367,070 recoverable advance.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Coverage of the Company\u2019s share&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The Company retained the Edison Group as an analyst to carry out a study into initiating financial coverage. This research contract, financed by the Company, aims to enable investors to broaden their understanding of the Company, which is necessary to take up positions on Amo\u00e9ba shares (ALMIB).&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>On April 20, Amo\u00e9ba also welcomed Portzamparc &#8211; BNP Paribas Group on board to start covering its share. It began its monitoring with a \u201cBuy\u201d recommendation and a study entitled: \u201cAmoeba supporting the environment\u201d.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Governance&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>At their Combined General Meeting on May 25, 2023, the Company\u2019s shareholders decided to: renew the terms of office of Mr Plasson, Mr Dujardin, Mr Ambollet, Ms Guinard and Ms Filiatre, which had expired, for a six-year period through to the end of the Ordinary Annual General Meeting held in 2029 to approve the accounts for the year ending December 31, 2028.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>appoint Mr Jean Luc Souche (previously Biocontrol Business Developer with Amo\u00e9ba) as a new director.&nbsp;<\/li>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li><\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>The Board of Directors, which held its first session following the General Meeting, reappointed Mr Fabrice Plasson as Chairman of the Board of Directors and Chief Executive Officer for the duration of his term of office as a director.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<ul class=\"wp-block-list\"><div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<li>Val\u00e9rie Filiatre, who opted to retire this year, will continue to support Amo\u00e9ba\u2019s development as a director. Jean-Fran\u00e7ois DOUCET, who joined the company in May 2023, is now Deputy Managing Director.&nbsp;<\/li>\n<\/div><\/div><\/div><\/ul>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><em>\u201cI would like to sincerely thank Val\u00e9rie for her work with the company since 2014 and her commitment working alongside me during all these years. I wish her every happiness in her new projects, and I am delighted that she will continue to support the company as a director\u201d<\/em>, confirms Fabrice Plasson, Chairman and CEO.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Events since 30 June&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>On the biocontrol application&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>Amo\u00e9ba confirms that the regulatory timetable for applying for approval of the biocontrol active substance is in line with the company&#8217;s forecasts (see press release from July 13, 2023).&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Financing&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company has drawn down the 1st tranche of 100 straight bonds subscribed to in favour of Nice &amp; Green SA for a net amount of \u20ac2,820,000 paid in July 2023 and August 2023.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company is continuing its search for additional financing. Following an initial financial diagnosis and structuring phase carried out by Redbridge Debt and Treasury Advisory, the Company is continuing its fund-raising strategy with KPMG.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Investments&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company confirms the progress of its project for a production site dedicated to biocontrol applications and announces that the deed of purchase for the land to house this plant in Cavaillon was signed on September 26, 2023.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Development and outlook&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Biocontrol application&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>The Company is moving forward with its project to develop its first biocontrol plant. This plant, which will be located in Cavaillon in the South of France, is expected to be operational during the first quarter 2025 to align with sales of the biocontrol products.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>Biocide application&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>Following the US EPA&#8217;s preliminary favorable decision on the use of the amoeba Willaertia Magna C2c Maky in closed cooling systems (see press release from August 10, 2022), Amo\u00e9ba has started to look for a partner that will be able to take on the production and\/or marketing of its biocide product in the United States. This search is still ongoing.&nbsp;<\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><strong>On the reporting date for the accounts, the Company has sufficient net working capital to cover its obligations and cash requirements through to June 30, 2024, and believes that it is in a position to deliver on the commitments that it has made to date.&nbsp;<\/strong><\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p>Read the press release in PDF : <\/p>\n<\/div><\/div><\/div>\n\n<div class=\"container\"><div class=\"row\"><div class=\"medium-large-full\">\n<p><a href=\"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/CP-231005-Resultat-semestriel_vDef_-ENG.pdf\">https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/CP-231005-Resultat-semestriel_vDef_-ENG.pdf<\/a><\/p>\n<\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Amo\u00e9ba: a first half-year mainly marked by the development of the biocontrol plant project&nbsp; Chassieu (France), October 5, [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":5384,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-5387","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba\" \/>\n<meta property=\"og:description\" content=\"Amo\u00e9ba: a first half-year mainly marked by the development of the biocontrol plant project&nbsp; Chassieu (France), October 5, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/\" \/>\n<meta property=\"og:site_name\" content=\"Amoeba\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-05T16:00:16+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-05T16:10:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"512\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"alellu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"alellu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/\"},\"author\":{\"name\":\"alellu\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#\\\/schema\\\/person\\\/90104d64ffd447439431f5a129e43993\"},\"headline\":\"Amo\u00e9ba: first half-year reporting\u00a0\",\"datePublished\":\"2023-10-05T16:00:16+00:00\",\"dateModified\":\"2023-10-05T16:10:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/\"},\"wordCount\":1570,\"publisher\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/site.png\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/\",\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/\",\"name\":\"Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/site.png\",\"datePublished\":\"2023-10-05T16:00:16+00:00\",\"dateModified\":\"2023-10-05T16:10:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/site.png\",\"contentUrl\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2023\\\/10\\\/site.png\",\"width\":1024,\"height\":512},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/amoeba-first-half-year-reporting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amo\u00e9ba: first half-year reporting\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/\",\"name\":\"Amoeba\",\"description\":\"Fight Pathogens, Respect Nature\",\"publisher\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#organization\",\"name\":\"Amoeba\",\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo-amoeba-blanc.svg\",\"contentUrl\":\"https:\\\/\\\/amoeba-nature.com\\\/wp-content\\\/uploads\\\/2021\\\/03\\\/logo-amoeba-blanc.svg\",\"width\":482,\"height\":296,\"caption\":\"Amoeba\"},\"image\":{\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/amoeba-nature\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/#\\\/schema\\\/person\\\/90104d64ffd447439431f5a129e43993\",\"name\":\"alellu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g\",\"caption\":\"alellu\"},\"url\":\"https:\\\/\\\/amoeba-nature.com\\\/en\\\/author\\\/marmanet\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/","og_locale":"en_US","og_type":"article","og_title":"Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba","og_description":"Amo\u00e9ba: a first half-year mainly marked by the development of the biocontrol plant project&nbsp; Chassieu (France), October 5, [&hellip;]","og_url":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/","og_site_name":"Amoeba","article_published_time":"2023-10-05T16:00:16+00:00","article_modified_time":"2023-10-05T16:10:59+00:00","og_image":[{"width":1024,"height":512,"url":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png","type":"image\/png"}],"author":"alellu","twitter_card":"summary_large_image","twitter_misc":{"Written by":"alellu","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#article","isPartOf":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/"},"author":{"name":"alellu","@id":"https:\/\/amoeba-nature.com\/en\/#\/schema\/person\/90104d64ffd447439431f5a129e43993"},"headline":"Amo\u00e9ba: first half-year reporting\u00a0","datePublished":"2023-10-05T16:00:16+00:00","dateModified":"2023-10-05T16:10:59+00:00","mainEntityOfPage":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/"},"wordCount":1570,"publisher":{"@id":"https:\/\/amoeba-nature.com\/en\/#organization"},"image":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#primaryimage"},"thumbnailUrl":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/","url":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/","name":"Amo\u00e9ba: first half-year reporting\u00a0 - Amoeba","isPartOf":{"@id":"https:\/\/amoeba-nature.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#primaryimage"},"image":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#primaryimage"},"thumbnailUrl":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png","datePublished":"2023-10-05T16:00:16+00:00","dateModified":"2023-10-05T16:10:59+00:00","breadcrumb":{"@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#primaryimage","url":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png","contentUrl":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2023\/10\/site.png","width":1024,"height":512},{"@type":"BreadcrumbList","@id":"https:\/\/amoeba-nature.com\/en\/amoeba-first-half-year-reporting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/amoeba-nature.com\/en\/"},{"@type":"ListItem","position":2,"name":"Amo\u00e9ba: first half-year reporting\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/amoeba-nature.com\/en\/#website","url":"https:\/\/amoeba-nature.com\/en\/","name":"Amoeba","description":"Fight Pathogens, Respect Nature","publisher":{"@id":"https:\/\/amoeba-nature.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amoeba-nature.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/amoeba-nature.com\/en\/#organization","name":"Amoeba","url":"https:\/\/amoeba-nature.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/amoeba-nature.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2021\/03\/logo-amoeba-blanc.svg","contentUrl":"https:\/\/amoeba-nature.com\/wp-content\/uploads\/2021\/03\/logo-amoeba-blanc.svg","width":482,"height":296,"caption":"Amoeba"},"image":{"@id":"https:\/\/amoeba-nature.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/amoeba-nature"]},{"@type":"Person","@id":"https:\/\/amoeba-nature.com\/en\/#\/schema\/person\/90104d64ffd447439431f5a129e43993","name":"alellu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6c833bc55dad7c9f374b1bd195af51055c9b2325f7814ec13a2eb2f9adb4fe80?s=96&d=mm&r=g","caption":"alellu"},"url":"https:\/\/amoeba-nature.com\/en\/author\/marmanet\/"}]}},"_links":{"self":[{"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/posts\/5387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/comments?post=5387"}],"version-history":[{"count":3,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/posts\/5387\/revisions"}],"predecessor-version":[{"id":5399,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/posts\/5387\/revisions\/5399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/media\/5384"}],"wp:attachment":[{"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/media?parent=5387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/categories?post=5387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amoeba-nature.com\/en\/wp-json\/wp\/v2\/tags?post=5387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}